Preferences help
enabled [disable] Abstract
Number of results
2013 | 60 | 3 | 307-311
Article title

Metastasis inhibition after proton beam, β- and γ-irradiation of melanoma growing in the hamster eye

Title variants
Languages of publication
Standard ocular tumor treatment includes brachytherapy, as well as proton therapy, particularly for large melanoma tumors. However, the effects of different radiation types on the metastatic spread is not clear. We aimed at comparing ruthenium (106Ru, emitting β electrons) and iodine (125I, γ-radiation) brachytherapy and proton beam therapy of melanoma implanted into the hamster eye on development of spontaneous lung metastases. Tumors of Bomirski Hamster Melanoma (BHM) implanted into the anterior chamber of the hamster eye grew aggressively and completely filled the anterior chamber within 8-10 days. Metastases, mainly in the lung, were found in 100% of untreated animals 30 days after enucleation. Tumors were irradiated at a dose of 3-10 Gy with a 106Ru plaque and at a dose of 6-14 Gy using a 125I plaque. The protons were accelerated using the AIC-144 isochronous cyclotron operating at 60 MeV. BHM tumors located in the anterior chamber of the eye were irradiated with 10 Gy, for the depth of 3.88 mm. All radiation types caused inhibition of tumor growth by about 10 days. An increase in the number of metastases was observed for 3 Gy of β-irradiation, whereas at 10 Gy an inhibition of metastasis was found. γ-radiation reduced the metastatic mass at all applied doses, and proton beam therapy at 10 Gy also inhibited the metastastic spread. These results are discussed in the context of recent clinical and molecular data on radiation effects on metastasis.
Physical description
  • Bakewicz E, Budzanowski A, Taraszkiewicz R (2003) AIC-144 cyclotron: present status. Nukleonika 48: 117-121.
  • Bomirski A, Słominski A, Bigda J (1988) The natural history of a family of transplantable melanomas in hamsters. Cancer Metastasis Rev 7: 95-118.
  • COMS (2006) The COMS randomized trial of iodine 125 brachytherapy for choroidal melanoma: V. Twelve-year mortality rates and prognostic factors: COMS report No. 28. Archives Ophthalmol 124: 1684-1693.
  • Fokas E, Kraft G, An H, Engenhart-Cabillic R (2009) Ion beam radiobiology and cancer: time to update ourselves. Biochim Biophys Acta 1796: 216-229.
  • Fuks Z, Kolesnick R (2005) Engaging the vascular component of the tumor response. Cancer Cell 8: 89-91.
  • Fuss M, Loredo LN, Blacharski P, Grove RI, Slater JD (2001) Proton radiation therapy for medium and large choroidal melanoma: preservation of the eye and its functionality. Int J Radiat Oncol Biol Phys 49: 1053-1059.
  • Girdhani S, Sachs R, Hlatky L (2013) Biological effects of proton radiation: what we know and don't know. Radiat Res 179: 257-272.
  • Goetze K, Scholz M, Taucher-Scholz G, Mueller-Klieser W (2010) Tumor cell migration is not influenced by p21 in colon carcinoma cell lines after irradiation with X-ray or (12)C heavy ions. Radiation Environ Biophys 49: 427-435.
  • Gragoudas ES (2006) Proton beam irradiation of uveal melanomas: the first 30 years. The Weisenfeld Lecture. Investigative Ophthalmol Visual Sci 47: 4666-4673.
  • Höcht S et al. (2004) Proton therapy of uveal melanomas in Berlin. 5 years of experience at the Hahn-Meitner Institute. Strahlentherapie und Onkologie 180: 419-424.
  • Kleineidam M, Guthoff R (1994) Possible effects of radiobiological parameters on metastatic spread of uveal melanomas treated with 106Ru plaques. Ger J Ophthalmol 3: 22-25.
  • Kolesnick R, Fuks Z (2003) Radiation and ceramide-induced apoptosis. Oncogene 22: 5897-5906.
  • Kukielczak B, Romanowska B, Bryk J (1999) Gamma radiation and MC540 photosensitization of melanoma in the hamster's eye. Melanoma Res 9: 115-124.
  • Levin WP, Kooy H, Loeffler JS, DeLaney TF (2005) Proton beam therapy. Brit J Cancer 93: 849-854.
  • Lommatzsch PK, Werschnik C, Schuster E (2000) Long-term follow-up of Ru-106/Rh-106 brachytherapy for posterior uveal melanoma. Graefe's Archive Clin Exp Ophthalmol 238: 129-137.
  • Lorentini S, Amichetti M, Spiazzi L, Tonoli S, Magrini SM, Fellin F, Schwarz M (2012) Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma. A comparison with intensity-modulated radiotherapy and a spot size variation assessment. Strahlentherapie und Onkologie: Organ der Deutschen Röntgengesellschaft 188: 216-225.
  • Madani I, Neve W De, Mareel M (2008) Does ionizing radiation stimulate cancer invasion and metastasis. Bull Cancer 95: 292-300.
  • Martinou M, Giannopoulou E, Malatara G, Argyriou A, Kalofonos HP, Kardamakis D (2011) Ionizing radiation affects epidermal growth factor receptor signalling and metalloproteinase secretion in glioma cells. Cancer Genomics Proteomics 8: 33-38.
  • Matuszak Z, Romanowska-Dixon B, Skwara A, Urbanska K, Starzycka M (2000) The effects of irradiation with 106Ru and 125I on the growth and metastases of experimental melanoma. Curr Top Biophys 24: 79-82.
  • Michalec B, Swakoń J, Sowa U, Ptaszkiewicz M, Cywicka-Jakiel T, Olko P (2010) Proton radiotherapy facility for ocular tumors at the IFJ PAN in Kraków Poland. Appl Radiat Isot 68: 738-742.
  • Mizumoto M et al. (2010) Clinical results of proton-beam therapy for locoregionally advanced esophageal cancer. Strahlentherapie und Onkologie 186: 482-488.
  • Mizumoto M et al. (2011) Proton beam therapy for hepatocellular carcinoma: a comparison of three treatment protocols. Int J Radiat Oncol Biol Phys 81: 1039-1045.
  • Ogata T et al. (2005) Particle irradiation suppresses metastatic potential of cancer cells. Cancer Res 65: 113.
  • Ohuchida K (2004) Radiation to stromal fibroblasts increases invasiveness of pancreatic cancer cells through tumor-stromal interactions. Cancer Res 64: 3215-3222.
  • Onoda J, Piechocki M, Honn K (1992) Radiation-induced increase in expression of the alpha iibbeta 3 integrin in melanoma cells: effects on metastatic potential. Radiation Res 130: 281-288.
  • Park C-M, Park M-J, Kwak H-J, Lee H-C, Kim M-S, Lee S-H, Park I-C, Rhee CH, Hong S-I (2006) Ionizing radiation enhances matrix metalloproteinase-2 secretion and invasion of glioma cells through Src/epidermal growth factor receptor-mediated p38/Akt and phosphatidylinositol 3-kinase/Akt signaling pathways. Cancer Res 66: 8511-8519.
  • Qian L-W, Mizumoto K, Inadome N, Nagai E, Sato N, Matsumoto K, Nakamura T, Tanaka M (2003) Radiation stimulates HGF receptor/c-Met expression that leads to amplifying cellular response to HGF stimulation via upregulated receptor tyrosine phosphorylation and MAP kinase activity in pancreatic cancer cells. Int J Cancer 104: 542-549.
  • Romanowska-Dixon B, Urbanska K, Elas M, Cichocki T (2003) The histology of pigmented Bomirski melanoma growing in the hamster eye - preliminary results. Cell Mol Biol Lett 8: 849-856.
  • Romanowska-Dixon B, Urbańska K, Elas Martyna, Pajak Stanislawa, Zygulska-Mach H, Miodonski A, Urbanska K (2001) Angiomorphology of the pigmented Bomirski melanoma growing in hamster eye. Annals Anatomy 183: 559-565.
  • Swakon J et al. (2010) Facility for proton radiotherapy of eye cancer at IFJ PAN in Krakow. Radiation Measurements 45: 1469-1471.
  • Takahashi Y et al. (2003) Heavy ion irradiation inhibits in vitro angiogenesis even at sublethal dose. Cancer Res 63: 4253.
  • Urbanska K et al. (2000) Experimental ruthenium plaque therapy of amelanotic and melanotic melanomas in the hamster eye. Melanoma Res 10: 26-35.
  • Wild-Bode C, Weller M, Rimner A, Dichgans J, Wick W (2001) Sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma sublethal irradiation promotes migration and invasiveness of glioma cells: implications for radiotherapy of human glioblastoma. Cancer Res 61: 2744-2750.
Document Type
Publication order reference
YADDA identifier
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.